IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Teva names Makhteshim Agan boss as new CEO

7:58 AM MST | January 9, 2014 | Deepti Ramesh

Erez Vigodman. Teva Pharmaceutical Industries (PetaŠł• Tiqwa, Israel) says that Erez Vigodman, 54, has been appointed as president and CEO, effective 1 February. Teva announced on 30 October 2013 that its president and CEO, Jeremy Levin, had stepped down. Vigodman is currently president and CEO of Makhteshim Agan Industries (Tel Aviv), the world’s leading generic agrochemical company. Vigodman will retain that position until 6 February. Teva's group executive v.p. and CFO, Eyal Desheh, who filled the role of CEO on an interim basis, will now return to...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa